Verdict Medical Devices

Nexalin secures patent on brain stimulation method for substance use disorders

Nexalin has received patent approval from the USPTO for its DIFS method for treating substance use disorders (SUD). The post Nexalin secures patent on brain stimulation method for substance use disorders appeared first on Medical Device Network.

Apr 15, 2025 - 10:58
 0
Nexalin secures patent on brain stimulation method for substance use disorders
Nexalin has received patent approval from the USPTO for its DIFS method for treating substance use disorders (SUD).

The post Nexalin secures patent on brain stimulation method for substance use disorders appeared first on Medical Device Network.

Read More

Tags:

Previous Article

Azoth 3D adds Incus LMM for metal 3D printing

Next Article

FDA approves sale of Bruno Vision’s contact lenses with FusionTechnology

Related Posts

Cardiac Dimensions snags $53m for mitral valve device

Cardiac Dimensions snags $53m for mitral valve device

Mar 20, 2025  0

Neuranics secures $8m for TMR magnetic sensing technology growth

Neuranics secures $8m for TMR magnetic sensing technolo...

Apr 10, 2025  0

FDA approves GT Metabolic Solutions’ 50mm magnet in MagDI System

FDA approves GT Metabolic Solutions’ 50mm magnet in Mag...

Mar 12, 2025  0